| 2016 MASCC and ESMO guideline update for the prevention of chemotherapy-and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients F Roila, A Molassiotis, J Herrstedt, M Aapro, RJ Gralla, E Bruera, ... Annals of Oncology 27, v119-v133, 2016 | 588 | 2016 |
| participants of the MASCC/ESMO Consensus Conference Copenhagen 2015. 2016 MASCC and ESMO guideline update for the prevention of chemotherapy-and radiotherapy-induced nausea and … F Roila, A Molassiotis, J Herrstedt, M Aapro, RJ Gralla, E Bruera, ... Ann Oncol 27 (suppl 5), v119-v133, 2016 | 113 | 2016 |
| Efficacy and safety of fosaprepitant for the prevention of nausea and emesis during 5 weeks of chemoradiotherapy for cervical cancer (the GAND-emesis study): a multinational … CH Ruhlmann, TB Christensen, LH Dohn, M Paludan, E Rønnengart, ... The Lancet Oncology 17 (4), 509-518, 2016 | 64 | 2016 |
| 2016 updated MASCC/ESMO consensus recommendations: prevention of radiotherapy-induced nausea and vomiting CH Ruhlmann, F Jahn, K Jordan, K Dennis, E Maranzano, A Molassiotis, ... Supportive Care in Cancer 25, 309-316, 2017 | 46 | 2017 |
| Multinational study exploring patients’ perceptions of side-effects induced by chemo-radiotherapy CH Ruhlmann, TZ Iversen, M Okera, A Muhic, G Kristensen, P Feyer, ... Radiotherapy and Oncology 117 (2), 333-337, 2015 | 35 | 2015 |
| Neurokinin-1 receptor antagonists: review of their role for the prevention of chemotherapy-induced nausea and vomiting in adults M Karthaus, X Schiel, CH Ruhlmann, L Celio Expert review of clinical pharmacology 12 (7), 661-680, 2019 | 29 | 2019 |
| The Danish metastatic melanoma database (DAMMED): a nation-wide platform for quality assurance and research in real-world data on medical therapy in Danish melanoma patients E Ellebaek, IM Svane, H Schmidt, CA Haslund, M Donia, L Hoejberg, ... Cancer epidemiology 73, 101943, 2021 | 25 | 2021 |
| Palonosetron hydrochloride for the prevention of chemotherapy-induced nausea and vomiting C Ruhlmann, J Herrstedt Expert Review of Anticancer Therapy 10 (2), 137-148, 2010 | 25 | 2010 |
| Safety evaluation of aprepitant for the prevention of chemotherapy-induced nausea and vomiting CH Ruhlmann, J Herrstedt Expert Opinion on Drug Safety 10 (3), 449-462, 2011 | 24 | 2011 |
| Casopitant: a novel NK1-receptor antagonist in the prevention of chemotherapy-induced nausea and vomiting C Ruhlmann, J Herrstedt Therapeutics and Clinical Risk Management, 375-384, 2009 | 24 | 2009 |
| 2016 Updated MASCC/ESMO Consensus Recommendations: Controlling nausea and vomiting with chemotherapy of low or minimal emetic potential I Olver, CH Ruhlmann, F Jahn, L Schwartzberg, B Rapoport, ... Supportive Care in Cancer 25, 297-301, 2017 | 20 | 2017 |
| Palonosetron and prednisolone for the prevention of nausea and emesis during fractionated radiotherapy and 5 cycles of concomitant weekly cisplatin—a phase II study CH Ruhlmann, C Belli, T Dahl, J Herrstedt Supportive Care in Cancer 21, 3425-3431, 2013 | 19 | 2013 |
| Fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting CH Ruhlmann, J Herrstedt Expert review of anticancer therapy 12 (2), 139-150, 2012 | 16 | 2012 |
| Pigs as an infection source for methicillin resistant Staphylococcus aureus infections in humans CH Ruhlmann, HJ Kolmos, JE Kristiansen, R Skov Ugeskrift for laeger 170 (43), 3436-3436, 2008 | 16 | 2008 |
| Cannabis use among Danish patients with cancer: a cross-sectional survey of sociodemographic traits, quality of life, and patient experiences SW Nielsen, CH Ruhlmann, L Eckhoff, D Brønnum, J Herrstedt, SO Dalton Supportive Care in Cancer 30 (2), 1181-1190, 2022 | 15 | 2022 |
| participants of the MECCC (2016) 2016 MASCC and ESMO guideline update for the prevention of chemotherapy-and radiotherapy-induced nausea and vomiting and of nausea and vomiting … F Roila, A Molassiotis, J Herrstedt, M Aapro, RJ Gralla, E Bruera, ... Ann Oncol 27 (suppl 5), v119-v133, 2016 | 15 | 2016 |
| A national repository of complete radiotherapy plans: design, Results, and experiences SL Krogh, C Brink, EL Lorenzen, E Samsøe, IR Vogelius, R Zukauskaite, ... Acta Oncologica 62 (10), 1161-1168, 2023 | 8 | 2023 |
| Quality of life and mental health in real-world patients with resected stage III/IV melanoma receiving adjuvant immunotherapy S Pedersen, RB Holmstroem, A von Heymann, LK Tolstrup, K Madsen, ... Acta Oncologica 62 (1), 62-69, 2023 | 8 | 2023 |
| New treatments on the horizon for chemoradiotherapy-induced nausea and vomiting CH Ruhlmann, J Herrstedt Expert opinion on pharmacotherapy 17 (12), 1623-1629, 2016 | 7 | 2016 |
| 2023 MASCC and ESMO guideline update for the prevention of chemotherapy-and radiotherapy-induced nausea and vomiting J Herrstedt, R Clark-Snow, CH Ruhlmann, A Molassiotis, I Olver, ... ESMO Open, 102195, 2024 | 4 | 2024 |
